T 2168/21 (RNA cancer vaccines/BIONTECH) of 10.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T216821.20240410
- Date of decision
- 10 April 2024
- Case number
- T 2168/21
- Petition for review of
- -
- Application number
- 12723117.3
- IPC class
- A61K 39/00C12Q 1/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Individualized vaccines for cancer
- Applicant name
- BioNTech SE
TRON - Translationale Onkologie an der
Universitätsmedizin der Johannes Gutenberg-
Universität Mainz gemeinnützige GmbH - Opponent name
- IPrime Rentsch Kaelin AG (Opposition withdrawn)
Strawman Limited
Withers & Rogers LLP - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 54(2)European Patent Convention Art 54(3)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Grounds for opposition - subject-matter extends beyond content of earlier application (no)
Grounds for opposition - insufficiency of disclosure (no)
Novelty - (yes)
Inventive step - (yes)
Amendment to case - admissibly raised and maintained (no) - Catchword
- -
- Citing cases
- T 1909/23
Order
For these reasons it is decided that:
The appeal is dismissed.